C5 and paroxysmal nocturnal hemoglobinuria: In a subsequent study of 36 transfusion-independent patients with PNH, those who received eculizumab had significantly higher ferritin concentrations than patients who did not receive a C5 inhibitor and 13 out of 23 eculizumab treated patients had serum ferritin above the upper limit of the reference range [20].